Plasma ceramides are associated with MRI-based liver fat content but not with noninvasive scores of liver fibrosis in patients with type 2 diabetes

Abstract Background There is growing evidence that ceramides play a significant role in the onset and progression of non-alcoholic fatty liver disease (NAFLD), a highly prevalent condition in patients with type 2 diabetes associated with hepatic and cardiovascular events. However, the relationship b...

Full description

Bibliographic Details

Published in:	Cardiovascular Diabetology
Main Authors:	Damien Denimal, Sarah Béland-Bonenfant, Jean-Paul Pais-de-Barros, Alexia Rouland, Benjamin Bouillet, Laurence Duvillard, Bruno Vergès, Jean-Michel Petit
Format:	Article
Language:	English
Published:	BMC 2023-11-01
Subjects:	Type 2 diabetes Ceramides Liver steatosis Liver fibrosis
Online Access:	https://doi.org/10.1186/s12933-023-02049-2